MUMBAI : Zydus Animal Health and Investments Ltd (ZAHL), a wholly owned subsidiary of Cadila Healthcare Ltd, has entered into an agreement to sell its Animal Healthcare Established Markets Undertaking (Zydus AH) to a consortium led by private equity firm Multiples Alternate Asset Management for Rs2,921 crore.Zydus AH is the animal health business of ZAHL focused on India and certain other countries.The consortium, including Canada Pension Plan Investment Board and Rakesh Jhunjhunwala’s RARE Enterprises, has agreed to purchase the business through a special-purpose veZenex Animal Health India Pvt.